Pre-Admission Certification

Pre-admission certification, also known as pre-authorization or pre-certification, is a process in insurance where a healthcare service or treatment plan needs to be approved in advance by the insurance provider. The process helps to ensure that the proposed medical service or treatment is medically necessary, appropriate, and covered under the policy terms.

Here are some key features of pre-admission certification:

• The process may be required for various medical services, including hospitalization, surgeries, and medical tests.

• It is typically initiated by the healthcare provider or the patient before the service or treatment is scheduled.

• The insurance company may require the submission of medical records, test results, or other information to support the request for pre-admission certification.

• Once the request is received, the insurance company reviews the information and determines whether the proposed service or treatment is covered under the policy.

• If the request is approved, the insurance company will provide the patient with a confirmation of coverage, and the healthcare provider can proceed with the service or treatment.

• If the request is denied, the patient or healthcare provider may have the right to appeal the decision.

Here is an example of how pre-admission certification works:

John is scheduled for a knee surgery that requires hospitalization. Before the surgery, his healthcare provider submits a request for pre-admission certification to John's insurance company. The request includes John's medical history, diagnosis, and treatment plan. The insurance company reviews the request and approves the surgery as medically necessary and covered under John's policy. John receives a confirmation of coverage, and the surgery is performed as scheduled.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.